Wild type ATTR amyloidosis Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Feb 2026Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis

Region Skane — NA

TrialNOT YET RECRUITING

Dec 2025ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

Kotyora Family Medicine Health Management and Education Association — NA

TrialENROLLING BY INVITATION

Jun 2025Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

University Hospital, Lille

TrialNOT YET RECRUITING

Jan 2025Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

Sharmila Dorbala — PHASE3

TrialACTIVE NOT RECRUITING

Jan 2025PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Richmond Research Institute — NA

TrialRECRUITING

Jan 2025A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.

Medical University of Vienna

TrialRECRUITING

Oct 2024AI Echocardiographic Screening of Cardiac Amyloidosis

Cedars-Sinai Medical Center — NA

TrialENROLLING BY INVITATION

Jul 2024Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Gérond'if

TrialRECRUITING

May 2024MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

Centro Cardiologico Monzino

TrialRECRUITING

Jan 2024N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Weill Medical College of Cornell University — PHASE4

TrialENROLLING BY INVITATION

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Tegsedi

Ionis/AstraZeneca

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

AMVUTTRA

(VUTRISIRAN)Orphan drugsBLA

Alnylam Pharmaceuticals, Inc.

Approved Mar 2025FDA label ↗

Vyndaqel

(TAFAMIDIS MEGLUMINE)Orphan drug

Pfizer Laboratories Div Pfizer Inc

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

13 active trials

1Phase 3

1Phase 4

5N/A

6Unknown

13Total recruiting

Search clinical trials for Wild type ATTR amyloidosis →

Recent News & Research

No recent news articles indexed yet for Wild type ATTR amyloidosis.
Search PubMed for Wild type ATTR amyloidosis →

Browse all Wild type ATTR amyloidosis news →

Specialist Network

Top 6 by expertise

Mazen Hanna, MD, M.D

The Cleveland Clinic

📍 CLEVELAND, OH

Score 61 trial

Mathew S Maurer, MD

Columbia University

Score 51 trial

Jeff Packman, MBA

FoldRx Pharmaceuticals, Inc

Score 41 trial

MARK MCGOVERN, RN

Eidos Therapeutics, a BridgeBio company

Score 41 trial

John L Berk, M.D., D.D.S

Boston University

📍 CASTRO VALLEY, CA

Score 41 trial

Nicolas Verheyen, Res Prof, MD PhD

Medical University of Graz

Score 31 trial

View all Wild type ATTR amyloidosis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰